M. Ozonas

Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma

A. Vicens, E. Pieras, P. Pizá, 2010, BJU international.

Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): positioning statement from the Spanish Association of Urology.

Lourenzo Fernández Prieto, E. Solsona, A. Rodríguez-Antolín, 2013 .

A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids.

J. Pontones, J. P. Burgués, J. Jiménez-Cruz, 2007, European urology.

Traumatic renal artery thrombosis.

C. Gutiérrez, F. Hidalgo, M. Rebassa, 1998, Scandinavian Journal of Urology and Nephrology.

Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma

A. Vicens, E. Pieras, P. Pizá, 2010, BJU international.